Women & Infants Hospital of Rhode Island is a women and infants' hospital in Providence, Rhode Island. It is the primary teaching hospital in obstetrics, gynecology, and newborn pediatrics of the Warren Alpert Medical School at Brown University.

There are 137 beds in Women and Infants Hospital.

During the past decade, Women and Infants Hospital conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 113 clinical trials were completed, i.e. on average, 86.9% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 51 clinical trials were completed. i.e. 94.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women and Infants Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "Women and Infants Hospital of Rhode Island" with 53 trials sponsored, "Gynecologic Oncology Group" with 48 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored and "GOG Foundation" with 11 trials sponsored. Other sponsors include 110 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women and Infants Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 56 trials as a collaborator, "Women and Infants Hospital of Rhode Island" with 17 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 10 trials as a collaborator and "Gynecologic Oncology Group" with 8 trials as a collaborator. Other collaborators include 191 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Women and Infants Hospital" are "Recurrent Ovarian Carcinoma" (30 trials), "Ovarian Cancer" (26 trials), "Recurrent Fallopian Tube Carcinoma" (24 trials), "Breast Cancer" (23 trials) and "Recurrent Primary Peritoneal Carcinoma" (23 trials). Many other conditions were trialed in "Women and Infants Hospital" in a lesser frequency.

Most popular intervention types in "Women and Infants Hospital" are "Drug" (187 trials), "Other" (130 trials), "Biological" (60 trials), "Procedure" (60 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Paclitaxel" (56 trials), "Quality-of-Life Assessment" (43 trials), "Carboplatin" (35 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "Women and Infants Hospital" are 245 trials for "Female" genders, 59 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Women and Infants Hospital". 1 are not yet recruiting, 40 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 142 completed trials in Women and Infants Hospital, 5 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Women and Infants Hospital, 34 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 53 trials that are defined as “Not Applicable".

Women and Infants Hospital has several departments that took part in Clinical trials: "Brown/ Women and Infants Hospital of Rhode Island, Center for Women's Pelvic Medicine and Reconstructive Surgery" - 8 trials, "Women and Infants Hospital, Program in Women's Oncology" - 2 trials